Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

Smeland, Sigbjørn, Bielack, Stefan S., Whelan, Jeremy, Bernstein, Mark, Hogendoorn, Pancras, Krailo, Mark D., Gorlick, Richard, Janeway, Katherine A. +44 more·2019·European Journal of Cancer

Cited by (720)

Items 401–500 of 720

  1. Complications and Outcome of Bone Sarcoma Patients with Limb Salvage using Liquid Nitrogen-treated Bone for Reconstruction.
    Muhammad Zoha Farooq, Muhammad Bilal Shafiq, Sajid Ali, Ilyas Rafi · 2024 · PubMed Central
  2. Comparative Analysis of Skip Metastasis in Pediatric Osteosarcoma: Clinical Features and Outcomes
    Hadeel Halalsheh, Shrouq Amer, Zaid Omari, Munir Shawagfeh, Mohammad Boheisi, Iyad Yasin Sultan · 2024 · Journal of Pediatric Hematology/Oncology
  3. Molecular characterization of Golgi apparatus-related genes indicates prognosis and immune infiltration in osteosarcoma
    Jian Zhang, Jiahao Liu, Rui Ding, Xinxin Miao, Jianjian Deng, Xiaokun Zhao, Tianlong Wu, Xigao Cheng · 2024 · Aging
  4. Dual role of autophagy in bone metastasis: mechanistic insights and therapeutic targeting
    Xinyi Gu · 2025 · American Journal of Clinical and Experimental Urology
  5. Gain and loss from transcatheter intra-arterial limb infusion of cisplatin for extremity osteosarcoma: a retrospective study of 99 cases in the past six years
    Lu Xie, Jie Hua Xu, Sen Dong, Jian Gao, Xiaodong Tang, Taiqiang Yan, Rongli Yang, Wei Guo · 2019 · Cancer Management and Research
  6. Intercalary reconstruction of long bones by massive allograft: Comparison of construct stability ensured by three different host-graft junctions and two types of fixations in a synthetic femur model
    Massimiliano Baleani, Paolo Erani, Manon Blaise, Roberta Fognani, Marco Palmas, Marco Manfrini · 2022 · Frontiers in Pediatrics
  7. Ultra-Late Osteosarcoma Recurrences: An Analysis of 17 Cooperative Osteosarcoma Study Group Patients with a First Recurrence Detected More Than 10 Years After Primary Tumor Diagnosis
    Stefanie Hecker‐Nolting, Leo Kager, Thomas Kühne, Daniel Baumhoer, Claudia Blattmann, Godehard Friedel, Thekla v. Kalle, Mathias Kevric, Regine Mayer‐Steinacker, Rudolf Schwarz et al. · 2022 · Journal of Adolescent and Young Adult Oncology
  8. DPY30 promotes the growth and survival of osteosarcoma cell by regulating the PI3K/AKT signal pathway
    Gong Cheng, Fengmin An, Zhilin Cao, Mingdi Zheng, Zhongyuan Zhao, Hao Wu · 2022 · European Journal of Histochemistry
  9. Doxorubicin Dose Deintensification in Pediatric Osteosarcoma, Is Less Better?
    Hadeel Halalsheh, Ramiz Ahmad Abu-Hijlih, Taleb Ismael, Ahmad M. Shehadeh, K. J. Salaymeh, Mohammad Boheisi, Iyad Yasin Sultan · 2023 · South Asian Journal of Cancer
  10. Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung
    Lu Xie, Zhenyu Cai, Hezhe Lu, Fanfei Meng, Xin Zhang, Kun Luo, Xiaoxing Su, Lei Yan, Jiuhui Xu, Jingbing Lou et al. · 2023 · Heliyon
  11. Radiation Exposure in Pediatric Sarcoma Patients Receiving Initial Curative Chemotherapy
    Kelsey T. Danley, Nitin P. Sane, Paul M. Kent · 2019 · Journal of Pediatric Hematology/Oncology
  12. Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy
    Xiaofei Feng, Zhenrui Zhao, Yuhao Zhao, Zhengdong Song, Yao Ma, Wenji Wang · 2022 · Frontiers in Molecular Biosciences
  13. Acute generation of reactive oxygen species that induced by doxycycline pretreatment results in rapid cell death in polyphyllin G‐treated osteosarcoma cell lines
    Yi‐An Li, Hsuan‐Ying Chen, Cheng‐Pu Hsieh, Chiu‐Liang Chen, Shih‐Chieh Hung, Yi‐Fu Huang · 2023 · Environmental Toxicology
  14. BCM PDX Portal: An Intuitive Web-based Tool for Patient-Derived Xenograft Collection Management, as well as Visual Integration of Clinical and Omics Data
    Heidi Dowst, Apollo McOwiti, Fei Yan Zheng, Ramakrishnan Rajaram Srinivasan, Anadulce Hernández-Herrera, Nino Carlo Rainusso, Lisa Brubaker, Qizhi Cathy Yao, Michelle Redell, Alexandra McLean Stevens et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  15. Lung metastases pattern in limb osteosarcoma: A population-based study from 2010 to 2018
    Binbin Liu, Liyuan Tang · 2022 · Medicine
  16. Tandem mass tag (TMT) quantitative protein analysis‐based proteomics and parallel reaction monitoring (PRM) validation revealed that MST4 accelerates osteosarcoma proliferation by increasing MRC2 activity
    Yunyan Liu, Xiaoyu Zhang, Xingguang Ren, Jin Sun, Yanhua Wen, Zheng Guo, Qiong Ma · 2023 · Molecular Carcinogenesis
  17. Apatinib plus chemotherapy for non-metastatic osteosarcoma: a retrospective cohort study
    Jiaqiang Wang, Fan Zhang, Shuping Dong, Yang Yang, Fangfang Gao, Guancong Liu, Peng Zhang, Xin Wang, Xinhui Du, Zhichao Tian · 2023 · Frontiers in Oncology
  18. Prognostic value of pretreatment platelet count, fibrinogen and d-dimer levels in osteosarcoma patients: A meta-analysis
    Xianfeng Li, Honghong Ren, Lipeng Peng, Jie Li · 2024 · Medicine
  19. Periprosthetic seromas and a third space effect after high-dose methotrexate
    Claudia Prattes, Andreas Leithner, Joanna Szkandera, Georg Prattes, Ernst-Christian Urban, Andrea Eder-Halbedl, Volker Strenger · 2024 · Wiener klinische Wochenschrift
  20. Predictive Factors for Lung Metastasis in High-Grade Osteosarcoma: A 5 Years Experience from Tertiary Referral Hospital
    Yuni Artha Prabowo Putro, Rahadyan Magetsari, Yunus Oksikimbawan Tampubolon, Ahmad Faiz Huwaidi, Annissa Rosfadilla · 2024 · Acta Orthopaedica Belgica
  21. A comprehensive clinico-pathological review of a series of pediatric, adolescents and young adults with high-grade osteosarcoma: from clinics to biomarker discovery
    Susana Buendía López, Alba Rubio‐San‐Simón, Jen-Hao Wu, Daniel Azorín Cuadrillero, Ana Sanz-Miguel, Álvaro Lassaletta, Sara Inmaculada Sirvent-Cerdá, Laura Rey-Portela, Juan Carlos Abril, Lucas Moreno et al. · 2025 · Clinical & Translational Oncology
  22. The prognostic value of the central location of pulmonary nodules in osteosarcoma patients
    Gehad Ahmed, Maged M. Elshafiey, Marwa Abd El-hamied Romeih, Ahmed Kamel, Ahmed Elgammal, Asmaa Salama, Yomna AboTabl, Mohammad Taher · 2025 · Discover Oncology
  23. Pediatric Craniofacial Osteosarcoma: The Milano Experience
    Cristina Meazza, Francesca Parisi, Francesco Barretta, Giovanna Sironi, Olga Nigro, Carlo Morosi, Roberto Luksch, Marta Giorgia Podda, Andrea Ferrari, Monica Terenziani et al. · 2025 · Pediatric Blood & Cancer
  24. A perspective on patient-derived orthotopic xenograft (PDOX) mouse models for identification of novel and individualized treatment for sarcoma
    Takashi Higuchi, Kentaro Igarashi, Shinji Miwa, Hiroaki Kimura, Katsuhiro Hayashi, Satoru Demura, Sei Morinaga, Yohei Asano, Norio Yamamoto, Francis John Hornicek et al. · 2025 · International Journal of Clinical Oncology
  25. Heterogeneity in Osteosarcoma Revealed by scRNA Sequencing: CLU + Endothelial Cells as Key Players in Tumor Progression
    Zhehao Dai, Peng Xie, Xiangzhi Bai, Tang Liu, Xiaoning Guo, Lei Kuang, Ping Mu, Fangjin Lu · 2025 · Cancer Science
  26. Silencing of SOD1 sensitises ATRX-deficient cells to camptothecin treatment through increased activity of the alternative lengthening of telomeres pathway
    Natalie Mattis, Tomas Goncalves, Kanggeon Kim, Ester M. Hammond, Anna M. Rose · 2025 · Human Molecular Genetics
  27. Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group ( COSS )
    Stefan Bielack, Vanessa L. Mettmann, Daniel Baumhoer, Andreas Beilken, Claudia Blattmann, Godehard Friedel, Jendrik Hardes, Wolf Achim Hassenpflug, Leo Kager, Matthias Kevric et al. · 2025 · Cancer Medicine
  28. Metastatic osteosarcoma, patterns of care and outcomes of patients in a real‐life national setting over a decade
    Mathilde Reich, Derek Dinart, Hélène Bellio, Juliane Berchoud, Myriam Jean‐Denis, Maeva Bonneau, Sarah Winter, Maxime Brunet, Romain Duong, Simon Nannini et al. · 2025 · International Journal of Cancer
  29. CD3L1 expression and its association with the tumor microenvironment in 62 cases of osteosarcoma and Chordoma
    Yuhang Wang, Jiuhui Xu, Shouyan Deng, Kunkun Sun, Yaqi Wang, Tingting Ren, Xiaodong Tang, Jie Hua Xu, Lu Xie · 2025 · Scientific Reports
  30. Management of pediatric bone sarcomas
    Leighton Andrew Elliott, David Mark Loeb, Matteo Maria Trucco · 2025 · Current Opinion in Pediatrics
  31. Preliminary Surgical Findings and Complications After National Centralization of Pediatric Bone Sarcoma Resections in the Netherlands: A Benchmarking Study
    Lia Schalkwijk, Jasper M. van der Zee, Roelof van Ewijk, Johannes H. M. Merks, Jos A. M. Bramer, Hendrik W. B. Schreuder, Lianne Haveman, Michiel A. J. van de Sande, Lizz van der Heijden · 2025 · Clinical Orthopaedics and Related Research
  32. Time to treatment initiation and overall survival in osteosarcoma: a national cancer database analysis
    Sawyer H. Farmer, Aidan C. O'Brien, Paul J. Feustel, Matthew R. DiCaprio · 2026 · Bone & Joint Open
  33. METTL3-mediated m6A modification of CACNA1E promotes osteosarcoma progression and chemoresistance by enhancing WNT7B-mediated Ca2+ signaling
    Chaotao Chen, Kai Xiong, Feiyuan Liang, Yanping Zhong, Xiong Qin, Nanchang Huang, Yuqi Fang, Bo Zhu, Jianwen Cheng, Qingjun Wei et al. · 2026 · Molecular Cancer
  34. Epidemiology and Prognosis of Patients With Osteosarcoma at Different Primary Sites: A SEER Population‐Based Study
    Jianqun Wang, Linglong Zeng, Xiaoxia Li, Fan Xiaozhen, Zilong Yan, Hongwen Xu, Federico Canavese, Shiyu Li, Xinwang Zhi · 2026 · Cancer Reports
  35. Vitamin D receptor (VDR) expression in osteosarcoma and its association with histological subtypes and metastasis
    I. Baly, Dian Caturini Sulistyoningrum, Yuni Artha Prabowo Putro, Irianiwati Widodo, Ery Kus Dwianingsih · 2026 · Scientific Reports
  36. Prevalence and risk factors of distant metastasis among Chinese osteosarcoma patients: a systematic review and meta-analysis
    Xinyu Huang, Sanmao Liu, Jiaxing Zeng, Shunyu Lu · 2026 · Journal of Orthopaedic Surgery and Research
  37. Immunotherapy of Osteosarcoma
    Agnes L. Sorteberg, Linnea Ek, Ingrid Lilienthal, Nikolas Herold · 2023 · Springer eBooks
  38. A short-term three dimensional culture-based drug sensitivity test is feasible for malignant bone tumors
    Hiroaki Goto, Takashi Ohtsu, Mieko Ito, Maiko Sagisaka, Takuya Naruto, J. Nagai, N. Kitagawa, Mio Tanaka, Masakatsu Yanagimachi, Yukihiko Hiroshima et al. · 2023 · Human Cell
  39. Effects of combined sintilimab and chemotherapy on progression-free survival and overall survival in osteosarcoma patients with metastasis
    Li Fan, De-bao Zhang, Yue Ma, Yang Song, Xian-liang Duan · 2024 · Pakistan Journal of Medical Sciences
  40. Extent of Surgery and Survival of Osteosarcoma: A Retrospective Population-Based Study
    Connor J. Tupper, Emily A. Reeson, Michael R. Burdyny, Vincent P. Eaton, Peter T. Silberstein · 2024 · Cureus
  41. Survival analysis and prognostic model establishment of secondary osteosarcoma: a SEER-based study
    Jing Wang, Gongbo Fu, Zhongxiu Zhu, Lan Ding, Yitian Chen, Huiyu Li, Dan Xiang, Zhe Dai, Jialong Zhu, Linlin Ji et al. · 2024 · Annals of Medicine and Surgery
  42. miR-939, as an important regulator in various cancers pathogenesis, has diagnostic, prognostic, and therapeutic values: a review
    Hosein Kouchaki, Parnia Kamyab, Farzaneh Darbeheshti, Arezou Gharezade, Hamed Fouladseresht, Reza Tabrizi · 2024 · Journal of the Egyptian National Cancer Institute
  43. Long term survival in adult osteosarcoma patients treated with a two-drug regimen: Final results of the OSAD93 phase II study of the FSG-GETO
    Jean‐Yves Blay, Nicolas Penel, Maud Toulmonde, Thibaud Valentin, L. Chaigneau, María Rios, Esma Saâda-Bouzid, Nelly Firmin, François Bertucci, Perrine Marec‐Bérard et al. · 2024 · European Journal of Cancer
  44. Evaluation of Indoleamine 2,3-Dioxygenase (IDO) Expression in Osteosarcoma: Insights From a 10-Year Retrospective Cohort
    Asim Farooq, Aatif Amin, Shaarif Bashir, Merium Fatima, Muhammad Jawad Hassan, Ali Sheikh, Muhammad Tahseen, Umer Sheikh, Kashif Asghar · 2025 · OncoTargets and Therapy
  45. Multi‐Targeted Kinase Inhibitor Therapy in Pediatric Bone and Soft Tissue Sarcoma Patients—A Single Centre Experience
    Anna Mohás, Klára Horváth, Zsuzsanna Jakab, Monika Csóka · 2025 · Cancer Medicine
  46. miR-486-3p Suppresses Osteosarcoma Proliferation and Migration by Targeting the SPRED1-MAPK/ERK Pathway
    Yu Zhang, Yi Zhou, Sen Zhang, Xiaoying Zhang, Jiaxin Li, Xiaokai Zhan · 2025 · Biochemical Genetics
  47. Quinacrine induces autophagy via the Dlg5/AKT pathway to inhibit osteosarcoma cell proliferation and suppresses migration and invasion through the Dlg5/Girdin pathway
    Hongyu Li, Wenkai Chen, Xiangchen Zeng, Ronghai He, Guangrong Ji · 2025 · Phytomedicine
  48. Leukoencephalopathy, a Frequent Complication After High‐Dose Methotrexate in Treatment of Osteosarcoma
    Sandra Raimbault, Jean-Louis Amegnizin, Audrey Longaud, Brice C. Fresneau, Nathalie Gaspar, Pablo Berlanga, Virginie Kieffer, Anne Maraval, Lucy Métayer, Christelle Dufour et al. · 2025 · Pediatric Blood & Cancer
  49. Temporal evolution of metastatic disease: part I—an in-depth review of the evolution of metastatic disease across diverse spectrum of non-neural solid tumors on serial oncologic imaging studies and relevant practical applications
    Nahyun Jo, Leonardo P. Marcal, Venkata Subbiah Katabathina, Ajaykumar C. Morani, Medhini Rachamallu, Srinivasa R. Prasad, Sireesha Yedururi · 2021 · Japanese Journal of Radiology
  50. Metastatic osteosarcoma bowel perforation secondary to chemotherapy-induced tumour necrosis
    Megha Bhadbhade, Elizabeth A. Connolly, Sarit Badiani, David Andrew Yeo, Vivek A. Bhadri · 2022 · BMJ Case Reports
  51. A retrospective case–control study for the comparison of 5-year survival rates: the role of adjuvant and neoadjuvant chemotherapy in craniofacial bone sarcoma in adults
    Elena Hofmann, Saskia Preißner, Moritz Hertel, Robert Preißner, Carsten Rendenbach, Anne Flörcken, Max Heiland · 2023 · Therapeutic Advances in Medical Oncology
  52. Primär maligne Knochentumoren
    Philipp Theodor Funovics · 2023 · Die Orthopädie
  53. Osteosarcoma cells exhibit functional interactions with stromal cells, fostering a lung microenvironment conducive to the establishment of metastatic tumor cells
    M. Alvarez, Luciana M. Gutiérrez, Juan Bayo, María J. Cantero, Mariana Gabriela García, Marcela Fabiana Bolontrade · 2024 · Molecular Biology Reports
  54. Novel biomarkers in bone sarcomas — diagnosis, treatment selection, and clinical trials
    Anna Malgorzata Czarnecka, Piotr Błoński, Paulina Chmiel, Piotr Lukasz Rutkowski · 2024 · Oncology in Clinical Practice
  55. An immune-related eleven-RNA signature-drived risk score model for prognosis of osteosarcoma metastasis
    Jia-Song Teng, Yang Wang · 2024 · Scientific Reports
  56. Implementation of artificial intelligence in detection, classification, and prognostication of osteosarcoma utilizing different assessment techniques: a systematic review
    Zhina Mohamadi, Paniz Partovifar, Helia Ahmadzadeh, Elmira Ali Ahmadi, Ali Ghanbari, Sina Feyzipour, Fatemeh Atefat, Nazanin Jahanpeyma, Fatemeh Haghighi asl, Armin ZarinKhat et al. · 2025 · Intelligence-Based Medicine
  57. Bayesian Optimization–Enhanced Machine Learning for Osteosarcoma Risk Stratification Based on Sphingolipid Metabolism
    Yujian Zhong, Ruyuan He, Zewen Jiang, Queran Lin, Fei Peng, Wenyi Jin · 2025 · Human Mutation
  58. Primary cutaneous extraskeletal osteosarcoma of the pretibial leg: A case report and summary of the literature
    Katherine S. Jerew, Darius R. Mehregan · 2021 · Journal of Cutaneous Pathology
  59. Management of Primary Aggressive Tumors of the Knee
    John R. Martin, Richard L. Auran, Michael D. Duran, Amalia M. de Comas, David Jacofsky · 2022 · The Journal of Knee Surgery
  60. A Novel Tool to Predict the Overall Survival of High-Grade Osteosarcoma Patients after Neoadjuvant Chemotherapy: A Large Population-Based Cohort Study
    Zhangheng Huang, Yu Wang, Ye Wu, Chuan Fei Guo, Weilong Li, Qingquan Kong · 2022 · Journal of Oncology
  61. Dedifferentiation in low-grade osteosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study
    Toshihide Hirai, Hiroshi Kobayashi, Eisuke Kobayashi, Masanori Saito, T. Akiyama, Kazutaka Kikuta, Takaaki Nakai, Makoto Endo, Shinji Tsukamoto, Michiyuki Hakozaki et al. · 2022 · International Journal of Clinical Oncology
  62. Gaining insights into virotherapy with canine models
    Jacob L. Léger, Lee‐Hwa Tai · 2023 · Molecular Therapy — Oncolytics
  63. Effect of Cisplatin Arterial Infusion (CAI) on Primary Nonmetastatic Pelvic Osteosarcoma: A Preliminary Study
    Xuantao Hu, Xia Chen, Tao Li, Zicheng Liu, Xiaoning Guo, Zhengxiao Ouyang · 2021 · Cancer Management and Research
  64. Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?
    Nurşah Eker, Gülnür Tokuç, Barış Yılmaz, Zeynep Aktaş, Onur Buğdaycı, Bülent Erol, emel senay, Seda Aras · 2021 · Journal of Adolescent and Young Adult Oncology
  65. A Surgical Approach to Pulmonary Metastasis in Children
    Jonathan Karpelowksy, Guido Seitz · 2021 · Surgical Oncology Clinics of North America
  66. Refusal of Adjuvant Therapies and Its Impact on Local Control and Survival in Patients with Bone and Soft Tissue Sarcomas of the Extremities and Trunk
    Franziska Mentrup, Alexander Klein, Lars Hartwin Lindner, Silke Birgit Nachbichler, Boris Michael Holzapfel, Markus Albertsmeier, Thomas Knösel, Hans Roland Dürr · 2024 · Cancers
  67. Targeting PERK-ATF4-P21 axis enhances the sensitivity of osteosarcoma HOS cells to Mppα-PDT
    Shenxi Zhong, Ye Zhang, Hai Mou, Changchun Jian, Qiu Huang, Yunsheng Ou · 2024 · Aging
  68. Prognositic value of anoikis and tumor immune microenvironment-related gene in the treatment of osteosarcoma.
    Dong Wang, Qing Deng, Yi Peng, Zhaochen Tong, Zixin Li, Liping Huang, Jin Zeng, Jinsong Li, Jinglei Miao, Shijie Chen · 2024 · PubMed Central
  69. MMP13 as an effective target of an active trifluoromethyl quinazoline compound against osteosarcoma
    Changhua Zhou, Ting Zhang, Jia Yu, Gang Yu, Sha Cheng, Hui Wu, Bixue Xu, Heng Luo, Xiaobin Tian · 2024 · Toxicology and Applied Pharmacology
  70. Identification and functional characterization of T-cell exhaustion-associated lncRNA AL031775.1 in osteosarcoma: a novel therapeutic target
    Yameng Wang, Jinghong Yuan, Keying Guo, Zhuoer Zhang, Junchao Zhu, Shahrzad Arya, Guowen Huang, Shengqin Li, Qi Chen, Xijuan Liu et al. · 2025 · Frontiers in Immunology
  71. NEK2 promotes the progression of osteosarcoma through the AKT/p-AKT pathway and interacts with FoxM1
    Xin Tan, Xiaojing Liang, Yi Feng, Ming Xie, Kun Zhong, Wenwu Luo, Yurao Wang, Yu Yin, Yongping Cai · 2025 · Medical Oncology
  72. Immunotherapy of Osteosarcoma
    Agnes L. Sorteberg, Linnea Ek, Ingrid Lilienthal, Nikolas Herold · 2025 · Springer eBooks
  73. Transphyseal tumor extension on initial magnetic resonance imaging (MRI) correlates with metastases in pediatric extremity osteosarcoma
    Adarsh Suresh, Andrew C. Sher, Nicole I. Montgomery, Nino Carlo Rainusso, Lisa L. Wang, J. Herman Kan · 2025 · Skeletal Radiology
  74. Telangiectatic osteosarcoma in children and adolescents: Experience of the Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology scientific and clinical group on studying sarcomas of the locomotor system
    Elena I. Konopleva, Alexander I. Karachunskiy, N. A. Bolshakov, Дмитрий Викторович Рогожин, Н. Г. Ускова, А. P. Shcherbakov, I. V. Sidorov, Олег Иванович Быданов, Galina A. Novichkova · 2025 · Bone and soft tissue sarcomas tumors of the skin
  75. Mouse Models of Osteosarcoma: Unraveling Disease Mechanisms and Accelerating Drug Discovery and Development
    Staci L. Haney, Sarah A. Holstein · 2025 · Cancer Reports
  76. Stereotactic Body Radiation Therapy Augmented Checkpoint Inhibitor Immunotherapy Response in Heavily Pretreated Metastatic Osteosarcoma
    Chuanying Zhu, Yichen Xu, Junxiang Wen, Zhusheng Zhang, Tao Liang, Xiaoyan Chen, Xue Wang, Qi Liu, Beichen Wang, Yucheng Fu et al. · 2025 · International Journal of Radiation Oncology*Biology*Physics
  77. HP1 enhances radio- and chemotherapy resistance in osteosarcoma via PARP1-dependent transcriptional repression and HR repair
    Yuanxin Zhu, Wenjia Li, Yuntan Qiu, Zhihuai Deng, Yu Li, Hengxing Chen, J. Zhang, Daning Lu, Kaishun Hu, Dongsheng Huang et al. · 2025 · Cancer Letters
  78. Sarcomas in Adolescents and Young Adults
    Jacob Ron Greenmyer, Wendy A. Allen‐Rhoades · 2026 · Current Oncology Reports
  79. Immunotherapeutic advances for the treatment of osteosarcoma, driven by studies in pet dogs with spontaneous disease
    Grace L. Edmunds, Nicola J. Mason · 2026 · Rare Disease and Orphan Drugs Journal
  80. Paediatric therapeutic development workshop on osteosarcoma
    Joseph S. Baxter, Claudia Montiel-Equihua, Jan J. Molenaar, Pablo Berlanga, Michael W. Bishop, Patricia Blanc, Quentin Campbell-Hewson, Michela Casanova, Isidro Cortés‐Ciriano, Brian D. Crompton et al. · 2026 · British Journal of Cancer
  81. Injectable borate/borosilicate bioactive glass systems for the regeneration of hard tissue – A critical review of the literature
    S-Sina Mohammadi, Sunjeev S. Phull, Ryan J. Gilbert, Mark R. Towler · 2026 · Engineered Regeneration
  82. Cross-cultural adaptation and validation of a self-reporting tool to assess health-related quality of life for Egyptians with extremity bone sarcomas in childhood or adolescence
    Nesma Farid, Sungsoo Chun, Omneya Hassanain, Mohamed Salama, Elham Esam, Fatima Adel, Ismail Rashad, Ahmed Mohamed El Ghoneimy · 2023 · Health and Quality of Life Outcomes
  83. Osteosarcoma Arising as a Secondary Malignancy following Treatment for Hematologic Cancer: A Report of 33 Affected Patients from the Cooperative Osteosarcoma Study Group (COSS)
    Stefan Bielack, Vanessa L. Mettmann, Daniel Baumhoer, Claudia Blattmann, Birgit Burkhardt, Christoph K.W. Deinzer, Leo Kager, Matthias Kevric, Christine Mauz‐Körholz, Peter Müller‐Abt et al. · 2024 · Cancers
  84. Quality of Life and Patient‐Reported Outcomes in Patients With Osteosarcoma: A Systematic Review
    Ana Sebio, Claire Berger, Marie‐Dominique Tabone, Natalia Fernández, Faustine Tardy, Martha Alexandra Grootenhuis, Emanuela Palmerini, Nathalie Gaspar, Michiel A. J. van de Sande, Lianne Haveman · 2025 · European Journal of Cancer Care
  85. Exploration of research hotspots and evolutionary trends in osteosarcoma pulmonary metastasis: A comprehensive bibliometric analysis spanning five decades
    Chaojie Yu, Xiaohua Jiang, Shutian Wei, Chengzhi Zhou, Chengyu Zhou, Yanshan Wei, Zhiping Su · 2025 · Journal of Orthopaedics
  86. A prediction model of pulmonary metastasis risk in pediatric patients with stage IIB osteosarcoma in the long bone of extremities
    Guodong Zhong, Wanzhen Wang, Aierxiding Aimaiti, Yongqian Wang, Xianbiao Xie, Changye Zou, Jun-Qiang Yin, Jingnan Shen, Gang Huang, Zhiqiang Zhao · 2025 · European Journal of Surgical Oncology
  87. Long Term Reproductive Health Outcomes in Women Treated for Osteosarcoma During Childhood: A Systematic Review
    Ursula Blyth, Shehani Alwis, Emerald Win OO, Pedro Melo, Suzannah A. Williams, Sheila M. Lane, Christian Malte Becker · 2025 · Journal of Pediatric and Adolescent Gynecology
  88. Spanish Paediatric Haematology and Oncology Survival Results and Trends, 1999–2022
    Pau Alfonso-Comos, Álvaro Briz‐Redón, José Luís Dapena, Susana Rives, Josep Navarro, Jaime Verdú‐Amorós, Adela Cañete, RETI-SEHOP Survival Working Group · 2026 · Cancers
  89. Activating GCN2 and subsequently the Unfolded Protein Response with the small oral molecule NXP800 delays tumor growth in osteosarcoma
    Emma Racineau, Morgane Lallier, Anaïs Postec, Jérôme Amiaud, Rose‐Anne Thépault, Régis Brion, Séverine Battaglia, Céline Charrier, Marie-Anne Colle, Bénédicte Brounais-Le Royer et al. · 2026 · Cell Death Discovery
  90. Adaptor protein CIN85 potentiates the motility of osteosarcoma cells via the Akt/ mTOR and MMP2 ‐ COL3A1 axis
    I. R. Horak, Iva Staniczková Zambo, Matěj Přikryl, Peter Múdrý, Danica Zapletalová, Jarmila Navrátilová, Jiří Navrátil, Jan Šmarda, Л. Б. Дробот, Petr Beneš et al. · 2026 · Molecular Oncology
  91. An international framework for clinical translation of molecular classifiers in osteosarcoma
    Amanda E. Marinoff, Michaela Nathrath, David Stephen Shulman, Sarah Burkhead Whittle, Jovana Pavisic, Dimitrios Spentzos, Catherine Michelle Albert, Joshua O. Nash, Adam Shlien, Isidro Cortés‐Ciriano et al. · 2026 · npj Precision Oncology
  92. Beyond ATRX: The heterogeneous basis of Alternative Lengthening of Telomeres in osteosarcoma
    Tomas Goncalves, Natalie Mattis, Amy F. Mitchell, Anna M. Rose · 2026 · Cancer Genetics
  93. Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service
    Reuben A. Hastings, Andrew Bacon, Victoria M. Vinader, Jennifer E. Gains, Sean McPhail, Lizz Paley, Craig Gerrand, Martin G. McCabe, Sandra J. Strauss · 2026 · European Journal of Cancer
  94. Systemische Therapie von Osteosarkomen
    Stefan Bielack, Peter Reichardt, Lars Hartwin Lindner, Stefanie Hecker‐Nolting · 2022 · Die Onkologie
  95. Chondroblastic osteosarcoma – Does this rare histological variant warrant a change in management?: A case report
    Satvik N Pai, Gopinath Menon, Giriraj Harshavardhan · 2022 · Journal of Orthopaedic Reports
  96. Molecular characterization of cancer-intrinsic immune evasion genes indicates prognosis and tumour microenvironment infiltration in osteosarcoma
    Xiaokun Zhao, Jian Zhang, Jiahao Liu, Shengzhong Luo, Rui Ding, Xinxin Miao, Tianlong Wu, Jingyu Jia, Xigao Cheng · 2023 · Aging
  97. What Is the Impact of Multimodal Treatment in Patients with Leiomyosarcoma of Bone? A Multicenter Study of 35 Patients with an Ultra-Rare Tumor Entity
    Maya Niethard, Carolin Knebel, Andreas Leithner, Per‐Ulf Tunn, Janosch Schoon, Peter Reichardt, Athanasios Pogkas, Joanna Szkandera, Daniel Pink, Dimosthenis Andreou · 2024 · Cancers
  98. Adjacent venous tumour thrombus in primary osteosarcoma of the pelvis and limbs
    Samuel E. Broida, Mikaela H. Sullivan, Peter S. Rose, Doris E. Wenger, Matthew T. Houdek · 2024 · The Bone & Joint Journal
  99. Gabapentin-Induced Adrenal Insufficiency: The Hypothalamic-Pituitary-Adrenal Axis Stress Misresponse and Risk of Infection: A Case Report and Literature Review
    Evmorfia Pechlivanidou, Alexandros Chatzikyriakos, Maria Anna Zisi, Nikolaos Paraskevopoulos, Semeli Kaltsa, Orestis Konstantas, Panteleimon N Zogakis, Aikaterini Catsouli, Nick Sekouris, Rodanthi E. Margariti · 2024 · Pharmaceuticals
  100. Outcomes with Methotrexate-Free Dyad Chemotherapy in Osteosarcoma Patients: Audit from a Resource-Limited Setting
    Nidhi Mimani Gupta, Kislay Dimri, Sudhir Kumar Garg, Awadhesh Kumar Pandey, Aanchal Arora · 2024 · Indian Journal of Medical and Paediatric Oncology